Our data show for the first time that CRC tumors have expression of AKR1B1 in both epithelial and stromal compartments; moreover, the relationship of AKR1B1 expression and clinical outcome depends highly on the TME content. The gene discussed is AKR1B1; the disease is colorectal carcinoma.